Nigeria: Copyright Commission Apprehends Broadcast Pirate in Osogbo

broadcast piracy

The Nigerian Copyright Commission (NCC) recently announced that in collaboration with Multichoice Nigeria Limited it carried out an anti-piracy raid at Dada Estate in Osogbo, Osun State. The raid, which took place on January 26, 2018, led to the arrest of one Mr. Idoni Joseph Osagie, and aligns with the Commission’s mission of fighting against infringements of broadcast rights in Nigeria.

According to the report released at the Commission’s headquarters in Abuja, the suspect was arrested at his residence with several incriminating items that aid broadcast piracy. The items included different types of decoders comprising five units of DSTV decoders, one unit of GOTV decoder, mounted decoders with a Pilot Television set, rolls of cables and a Client Register.

Other exhibits and contrivances used in the distribution of illegal broadcast signals were also sighted around the suspects flat such as large Rolls of Coaxial cables, Satellite dishes mounted and connected to the suspects flat and (10) Signal Boosters mounted on electric poles on the street and adjoining streets in the Neighborhood where the suspect resides.

Speaking about the arrest and investigation, NCC’s Ibadan Zonal Manager, Mrs. Ogundiran, stated that the suspect in the course of interrogation admitted to engaging in the illegal broadcast piracy due to the viability of the business.

The operation which was carried out after strategic surveillance by officials of Multichoice Nigeria was executed by a combined team of Copyright Inspectors and Staff of Multichoice Nigeria backed by armed policemen.

The suspect is currently out on bail while the investigation continues.

Print Friendly, PDF & Email
About Bob Aroture 564 Articles
Bob is a Senior Editor and Content Development Manager at Nigerian Law Intellectual Property Watch. He holds a BS degree, with a major in biochemistry. He works directly with the Newsroom Team. His focus areas are technology and innovation, and pharmaceutical technology. Email: